OncoSec Medical CEO Daniel O'Connor's 2021 pay jumps 122% to $3M
OncoSec Medical reports 2021 executive compensation
By ExecPay News
Published: May 31, 2022
OncoSec Medical reported fiscal year 2021 executive compensation information on May 31, 2022.
In 2021, three executives at OncoSec Medical received on average a compensation package of $1.8M, a 110% increase compared to previous year.
Average pay of disclosed executives at OncoSec Medical
Daniel J. O'Connor, Chief Executive Officer, received $3M in total, which increased by 122% compared to 2020.
Brian A. Leuthner, Chief Executive Officer, received a compensation package of $1.7M. 51% of the compensation package, or $856K, was in option awards.
Robert J. DelAversano, Principal Accounting Officer and Controller, earned $578K in 2021, a 48% increase compared to previous year.
OncoSec Medical's fiscal year ends on July 31.
Related executives
You may also like
Source: SEC filing on May 31, 2022.